Skip to main content
. 2022 Dec 16;16(6):064107. doi: 10.1063/5.0129602

FIG. 3.

FIG. 3.

CTC profiling in neoadjuvant breast cancer patients prior to treatment across stages II and III. (a) Overview of CTC phenotypes observed in healthy volunteers and stage II and III patients. (b) and (c) Profiling stage CTC sub-phenotypes in stage II and III treatment naïve breast cancer patients.